Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Fowler

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Neurology|June 17, 2024
Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer DiseaseYing Xia, Vincent Dore, Jurgen Fripp, et al.
ACS Chemical Neuroscience|January 15, 2015
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturationDominic J Hare, James D Doecke, Noel G Faux, et al.
Journal of Alzheimer'S Disease : JAD|February 23, 2017
Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)Bárbara R Cardoso, Dominic J Hare, Ashley I Bush, et al.
Alzheimer'S Research & Therapy|April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imagingJames D Doecke, Larry Ward, Samantha C Burnham, et al.
European Journal of Medicinal Chemistry|May 24, 2017
Novel propanamides as fatty acid amide hydrolase inhibitorsAlessandro Deplano, Carmine Marco Morgillo, Monica Demurtas, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 21, 2025
Combining Lumipulse p-tau217 and Aβ42/40 as confirmatory tests for Aβ positivity prior to disease-modifying therapyJames D Doecke, Ahmed Chenna, Mintzu Lo, et al.
Science Advances|February 1, 2021
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's diseaseYu-Hui Liu, Jun Wang, Qiao-Xin Li, et al.
Acta Neuropathologica|October 24, 2024
Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer's diseaseYe-Ran Wang, Xiao-Qin Zeng, Jun Wang, et al.
Journal of Medicinal Chemistry|October 3, 2013
Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitorsJayendra Z Patel, Teija Parkkari, Tuomo Laitinen, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Neurology|June 17, 2024
Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer DiseaseYing Xia, Vincent Dore, Jurgen Fripp, et al.
ACS Chemical Neuroscience|January 15, 2015
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturationDominic J Hare, James D Doecke, Noel G Faux, et al.
Journal of Alzheimer'S Disease : JAD|February 23, 2017
Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)Bárbara R Cardoso, Dominic J Hare, Ashley I Bush, et al.
Alzheimer'S Research & Therapy|April 3, 2020
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imagingJames D Doecke, Larry Ward, Samantha C Burnham, et al.
European Journal of Medicinal Chemistry|May 24, 2017
Novel propanamides as fatty acid amide hydrolase inhibitorsAlessandro Deplano, Carmine Marco Morgillo, Monica Demurtas, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 21, 2025
Combining Lumipulse p-tau217 and Aβ42/40 as confirmatory tests for Aβ positivity prior to disease-modifying therapyJames D Doecke, Ahmed Chenna, Mintzu Lo, et al.
Science Advances|February 1, 2021
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's diseaseYu-Hui Liu, Jun Wang, Qiao-Xin Li, et al.
Acta Neuropathologica|October 24, 2024
Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer's diseaseYe-Ran Wang, Xiao-Qin Zeng, Jun Wang, et al.
Journal of Medicinal Chemistry|October 3, 2013
Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitorsJayendra Z Patel, Teija Parkkari, Tuomo Laitinen, et al.
Pageof 17